Jacob S T, Rose K M
Adv Enzyme Regul. 1984;22:485-97. doi: 10.1016/0065-2571(84)90027-x.
Phosphorylation of poly(A) polymerase by protein kinase NI (a cyclic nucleotide-independent nuclear kinase closely associated with poly(A) polymerase at early stages of purification) resulted in as much as 7-fold activation of poly(A) polymerase. Phosphorylation causes an increase in the rate rather than the extent of polyadenylation. Antibodies raised in rabbits against purified poly(A) polymerase from Morris hepatoma 3924A reacted specifically with poly(A) polymerase following "Western" transfer of the enzyme onto diazobenzyloxyl methyl paper. Using iodinated enzyme, a competition radioimmunoassay for poly(A) polymerase was developed. Using the radioimmunoassay, it was shown that Morris hepatoma 3924A contains 100 micrograms of poly(A) polymerase/mg DNA or 10(7) molecules of the enzyme/cell nucleus. Nuclear poly(A) polymerase from fetal liver, but not from normal liver, was able to compete well with hepatoma enzyme in the radioimmunoassay. These data suggest that the tumor poly(A) polymerase is probably an oncofetal antigen, resulting from derepression of a gene not normally expressed in adult liver.
蛋白激酶NI(一种在纯化早期与聚腺苷酸聚合酶紧密相关的非环核苷酸依赖性核激酶)对聚腺苷酸聚合酶的磷酸化作用可使聚腺苷酸聚合酶的活性提高多达7倍。磷酸化导致聚腺苷酸化速率增加,而非程度增加。用兔抗来自莫里斯肝癌3924A的纯化聚腺苷酸聚合酶产生的抗体,在将该酶“Western”转移到重氮苄氧基甲基纸上后,能与聚腺苷酸聚合酶发生特异性反应。利用碘化酶,开发了一种聚腺苷酸聚合酶的竞争放射免疫测定法。通过放射免疫测定法表明,莫里斯肝癌3924A含有100微克聚腺苷酸聚合酶/毫克DNA或10⁷个该酶分子/细胞核。来自胎儿肝脏而非正常肝脏的核聚腺苷酸聚合酶,在放射免疫测定中能与肝癌酶进行良好竞争。这些数据表明,肿瘤聚腺苷酸聚合酶可能是一种癌胚抗原,是由成年肝脏中通常不表达的基因的去抑制产生的。